Federal health officials are backing the health benefits of nicotine pouches, ruling that Philip Morris International’s Zyn ...
Following an extensive scientific review, the U.S. Food and Drug Administration has authorized the marketing of 20 ZYN ...
The FDA said "an extensive scientific review" found the products were found to pose lower risks of cancer and other serious ...
Zyn is a pouch containing nicotine powder that is intended to rest in a user's mouth while the stimulant is absorbed into their bloodstream. The FDA's authorization of Zyn marks the first time ...
The FDA has authorized 20 ZYN nicotine pouch products from Philip Morris International (NYSE: PM), marking the first approval of its kind. After a thorough review, the FDA confirmed these products ...
The pouches are used by less than 2% of US teens, the FDA said in granting the application allowing them to continue to be ...
ZYN pouches contain no tobacco, only nicotine, offering a potentially less harmful option for tobacco users, with lower ...
The rule does not include e-cigarettes, nicotine pouches, noncombusted cigarettes such as heated tobacco products, waterpipe tobacco (hookah), smokeless tobacco products or premium cigars.
The proposed rule does not include e-cigarettes, nicotine pouches, noncombusted cigarettes, waterpipe tobacco, smokeless tobacco products, or premium cigars. In addition to preventing initiation ...
The FDA said the pouches contain substantially lower levels of harmful chemicals compared to cigarettes and most smokeless tobacco products, reducing risks of cancer and other serious health ...